Conformational changes in von Willebrand's factor protein: Effects on the binding of factor VIII‐coagulant
- 31 May 1986
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 22 (2) , 113-122
- https://doi.org/10.1002/ajh.2830220202
Abstract
The effects of conformational changes in purified canine von Willebrand's factor (VWF) were investigated to explore the relationship between its factor VIII‐related antigen (VIIIR:AG) and ristocetin cofactor (RCoF) properties and the factor VIII‐coagulant (VIII:C) binding site(s). Binding of VIII:C from canine von Willebrand's disease (VWD) plasma by VWF was used to measure the combining reaction of these proteins. The VWF was denatured to varying degrees by exposure to temperature and pH extremes, low ionic strength, and 6 M urea. Various treatments resulted in three types of change: elimination of RCoF, VIIIR:Ag, and VIII:C binding, removal of RCoF activity alone; or elimination of RCoF and retarded elution of VIIIR:Ag and VIII:C. As long as VIIIR:Ag reactivity was maintained, binding of VIII:C could be demonstrated; but in the absence of VIIIR:Ag, neither RCoF activity nor VIII:C binding remained. These results suggest that VIII:C binding and RCoF sites are separate on VWF and that interaction between VIII:C and VWF is possible even after significant structural changes occur in VWF. Furthermore, RCoF is more vulnerable to denaturation than the antigenic site. The spectrum of conformational changes that affect the properties of VWF may parallel the various recognized subtypes of VWD.Keywords
This publication has 24 references indexed in Scilit:
- Conformational domains and structural transitions of human von Willebrand proteinBiochemistry, 1984
- Crossed immunoelectrophoretic pre-peak of canine factor VIII-related antigenThrombosis Research, 1980
- The Factor VIII Abnormality in Severe von Willebrand's DiseaseNew England Journal of Medicine, 1979
- Ristocetin cofactor activity of purified canine factor VIII: Inhibition by plasma proteinsThrombosis Research, 1979
- Stabilization of Factor VIII in Plasma by the von Willebrand FactorJournal of Clinical Investigation, 1977
- Von Willebrand’s DiseaseNew England Journal of Medicine, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Willebrand Factor and Ristocetin II. RELATIONSHIP BETWEEN WILLEBRAND FACTOR, WILLEBRAND ANTIGEN AND FACTOR‐VIII ACTIVITYBritish Journal of Haematology, 1974
- Defective Ristocetin-Induced Platelet Aggregation in von Willebrand's Disease and its Correction by Factor VIIIJournal of Clinical Investigation, 1973
- FACTOR VIII COAGULANT ACTIVITY AND FACTOR VIII-LIKE ANTIGEN: INDEPENDENT MOLECULAR ENTITIESThe Journal of Experimental Medicine, 1973